Canada studies asthma drug Xolair risks

Thursday, August 13, 2009 - 11:56 in Health & Medicine

OTTAWA, Aug. 13 (UPI) -- Canadian officials say they are conducting a safety review of a potential link between the asthma drug Xolair and increased risk of cardiovascular problems.

Read the whole article on UPI

More from UPI

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net